Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Vps34-PIK-III
Cat. No.:
OB0225LY-0361
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Vps34-PIK-III is a complex associated with autophagy and membrane trafficking and is involved in a variety of cellular functions.
Synonym:
PIK-III; VPS34-IN2; 1383716-40-2; 4-(Cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-amine
CAS No.:
1383716-40-2
Compound CID:
67983123
Formula:
C17H17N7
Formula Weight:
319.36
Specification
Relative Density:
1.380 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Vps34-PIK-III can be used in cellular autophagy and endocytosis studies or play an important role in cancer and neurodegenerative disease research.
Library Information
Targets:
PI3K family
Receptors:
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ; Vps34
Pathways:
PI3K/Akt/mTOR signaling; Autophagy
Plate Number:
AOCL-5
Plate Location:
f6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 187.88 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
59 mg/mL; 184.7 mM
ALogP:
2.2
HBA_Count:
5
HBD_Count:
2
Rotatable Bond:
5
